---
figid: PMC9569594__ijms-23-11457-g009
figtitle: Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell
  Fraction Inducing Shift of Lipid to Glucose Metabolism
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC9569594
filename: ijms-23-11457-g009.jpg
figlink: /pmc/articles/PMC9569594/figure/ijms-23-11457-f009/
number: F9
caption: 'The relative concentrations of the metabolites. Notes: The relative concentrations
  of the metabolites involved in the glycolytic pathway and triacylglycerol pathway
  (part) in MDA-MB-231 cells (red) and MCF-7 cells (blue) after treatment with compound
  1 in duration of 48 h. Data are expressed as the mean value ± SD of three independent
  experiments. Columns, mean of cells; bars, SD; * p < 0.05; *** p < 0.001; SD, standard
  deviation; purple text indicates metabolites concentrations changed after treatment
  in both cell lines; ER, endoplasmatic reticulum; ADP, adenosine diphosphate; ATP,
  adenosine triphosphate; GLC-6-P, glucose-6-phosphate; glycerol-3-P, glycerol-3-phosphate;
  DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde 3-phosphate; Ac-CoA, acetyl-coenzyme
  A.'
papertitle: Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell
  Fraction Inducing Shift of Lipid to Glucose Metabolism.
reftext: Matij Pervan, et al. Int J Mol Sci. 2022 Oct;23(19):11457.
year: '2022'
doi: 10.3390/ijms231911457
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: breast cancer cells | cancer stem cells | newly synthesized thieno [2,3-b]pyridine
  compound | glycosphingolipids | metabolomics
automl_pathway: 0.8523024
figid_alias: PMC9569594__F9
figtype: Figure
redirect_from: /figures/PMC9569594__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9569594__ijms-23-11457-g009.html
  '@type': Dataset
  description: 'The relative concentrations of the metabolites. Notes: The relative
    concentrations of the metabolites involved in the glycolytic pathway and triacylglycerol
    pathway (part) in MDA-MB-231 cells (red) and MCF-7 cells (blue) after treatment
    with compound 1 in duration of 48 h. Data are expressed as the mean value ± SD
    of three independent experiments. Columns, mean of cells; bars, SD; * p < 0.05;
    *** p < 0.001; SD, standard deviation; purple text indicates metabolites concentrations
    changed after treatment in both cell lines; ER, endoplasmatic reticulum; ADP,
    adenosine diphosphate; ATP, adenosine triphosphate; GLC-6-P, glucose-6-phosphate;
    glycerol-3-P, glycerol-3-phosphate; DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde
    3-phosphate; Ac-CoA, acetyl-coenzyme A.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATPsynbeta
  - Atpalpha
  - adp
  - Gapdh2
  - CdGAPr
  - Gapdh1
  - RasGAP1
  - ArfGAP1
  - Aldh-III
  - Pa
  - Cont
---
